[1]
M. S. Khazaal, “Association between Dual-chamber (DDD) Pacemakers and Plasma Level of Soluble Suppression of Tumorigenicity-2 (sST2). A Case-Control Study in a Sample of Iraqi Patients”, Karb J Med, vol. 14, no. 1, pp. 2404–2411, Jun. 2021.